Canada on Saturday reported a second case of uncommon blood clots with low platelets after immunization with AstraZeneca’s COVID-19 vaccine in per week, whereas it stated it nonetheless advisable using the shot.
The one who skilled the very uncommon occasion has been handled and is recovering, Canada’s well being ministry stated in a press release, including that the particular person lives within the province of Alberta.
Based on the proof out there, Canada nonetheless maintains that the advantages of the AstraZeneca vaccine outweigh the potential dangers, the assertion stated.
Canada well being authorities “will continue to monitor the use of all COVID-19 vaccines closely and examine and assess any new safety concerns,” the assertion stated.
Canada reported a primary blood clotting related to the vaccine on Tuesday, and a day later, after a assessment, well being authorities stated they’d not limit use of the AstraZeneca vaccine.
A separate advisory council had earlier advisable Canada cease providing the vaccine to folks beneath 55. That panel is within the strategy of reviewing its recommendation.
Canada has been ramping up its vaccination marketing campaign, however nonetheless has a smaller share of its inhabitants inoculated than dozens of different nations, together with the United States and Britain.
Amid a spiking third wave of infections, Ontario, Canada’s most populous province, introduced new public well being restrictions on Friday, together with closing the provinces borders to home vacationers.
